← Back
$KYTX All transactions

Kyverna Therapeutics, Inc.

A

$ Value

$0

Shares

30,000

Price

$0

Filed

Jan 14

Insider

Name

Shaw Christi

Title

Executive Chairperson

CIK

0001702473

Roles

Director Officer

Transaction Details

Transaction Date

2026-01-12

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

46,634

Footnotes

Represents a restricted stock unit award of common stock, 1/4th of the shares subject to which shall vest on January 12, 2027, and 1/4th of the shares subject to the restricted stock unit award shall vest following each one-year period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive. | Represents a performance restricted stock unit award of common stock, which will vest upon the Issuer's common stock achieving certain specified prices per share. | 1/4th of the shares subject to the option shall vest on January 12, 2027, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Filing Info

Accession No.

0001193125-26-013021

Form Type

4

Issuer CIK

0001994702

Shaw Christi's History

Date Ticker Type Value
2026-01-12 KYTX A $0
2026-01-12 KYTX A $0
2026-01-12 KYTX A $0
2025-06-04 BEAM A $0
2025-05-29 KYTX A $0
2025-05-29 KYTX A $0

Other Insiders at KYTX (90d)

Insider Bought Sold Last
GRASSO MARC
Chief Financial Officer
2026-03-13
Miller Andrew Craig 2026-02-24
Emany Sravan Kumar 2026-02-24
Biddle Warner Weston
Chief Executive Officer
2026-03-13
GEHCHAN NAJI
See Remarks
2026-03-13
Pujols Mayobanex
Chief Technology Officer
2026-02-09